Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men

NCT03092960 is registered in ClinicalTrials.gov with Palo Alto Medical Foundation as lead sponsor.

NCT NCT03092960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men
Lead sponsor
Palo Alto Medical Foundation
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2017
Completion date
May 31, 2020
Enrollment
424 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lifestyle intervention, metabolic syndrome, obesity, pre diabetes